BOS
MDT icon

Bingham Osborn & Scarborough’s Medtronic MDT Stock Holding History

Bingham Osborn & Scarborough’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,902
Closed -$238K – 90
2021
Q3 		$238K Buy
1,902
+183
+11% +$23.7K 0.02% 140
2021
Q2 		$213K Buy
+1,719
New +$216K 0.02% 155

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bingham Osborn & Scarborough's MDT Position: Q4 2021 in Review

Bingham Osborn & Scarborough sold out of Medtronic (MDT) in Q4 2021, closing a stake of 1,902 shares — an estimated $238K sold.

Bingham Osborn & Scarborough first reported a position in MDT in Q2 2021 and held it in 2 quarters. The position peaked at $238K in Q3 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Bingham Osborn & Scarborough reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Bingham Osborn & Scarborough sold 1,902 Medtronic shares in Q4 2021, an estimated $238K.
  • Bingham Osborn & Scarborough first reported a position in Medtronic in Q2 2021 and held it in 2 quarters.
  • Bingham Osborn & Scarborough's Medtronic position peaked at $238K in Q3 2021.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Bingham Osborn & Scarborough's 13F filing for Q4 2021.